Found: 23
Select item for more details and to access through your institution.
New standard of care for multiple myeloma?
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 9, p. 1548, doi. 10.1002/cncr.35296
- By:
- Publication type:
- Article
Global phase 3 results show that bevacizumab with immunotherapy has activity in liver cancer.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 9, p. 1547, doi. 10.1002/cncr.35295
- By:
- Publication type:
- Article
Dynamic risk prediction model for multiple myeloma: Through deep learning, the model is able to adapt to future data, such as emerging treatment modalities and combinations.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 9, p. 1546, doi. 10.1002/cncr.35294
- By:
- Publication type:
- Article
Reply to "Mismatch repair and microsatellite instability—Recommendation for an optimal test strategy".
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 9, p. 1713, doi. 10.1002/cncr.35257
- By:
- Publication type:
- Article
Challenges in clinical trials for high‐risk but curable prostate cancer.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 9, p. 1575, doi. 10.1002/cncr.35245
- By:
- Publication type:
- Article
Practical guidance for direct oral anticoagulant use in the treatment of venous thromboembolism in primary and metastatic brain tumor patients.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 9, p. 1577, doi. 10.1002/cncr.35220
- By:
- Publication type:
- Article
Longitudinal adherence to annual colorectal cancer screening among Black persons living in the United States enrolled in a community‐based randomized trial.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 9, p. 1684, doi. 10.1002/cncr.35169
- By:
- Publication type:
- Article
Making progress against rare cancers: A case study on neuroendocrine tumors.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 9, p. 1568, doi. 10.1002/cncr.35184
- By:
- Publication type:
- Article
Estimation of age of onset and progression of breast cancer by absolute risk dependent on polygenic risk score and other risk factors.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 9, p. 1590, doi. 10.1002/cncr.35183
- By:
- Publication type:
- Article
Phase 2 trial of tremelimumab in patients with metastatic urothelial cancer previously treated with programmed death 1/programmed death ligand 1 blockade.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 9, p. 1642, doi. 10.1002/cncr.35179
- By:
- Publication type:
- Article
BRAF/MEK inhibitor rechallenge in advanced melanoma patients.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 9, p. 1673, doi. 10.1002/cncr.35178
- By:
- Publication type:
- Article
Mismatch repair and microsatellite instability—Recommendation for an optimal test strategy.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 9, p. 1711, doi. 10.1002/cncr.35211
- By:
- Publication type:
- Article
Urologist practice divestment from radiation vault ownership and treatment patterns for prostate cancer.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 9, p. 1609, doi. 10.1002/cncr.35168
- By:
- Publication type:
- Article
Erratum to "Patient‐reported outcomes with cemiplimab monotherapy for first‐line treatment of advanced non–small cell lung cancer with PD‐L1 of ≥50%: The EMPOWER‐Lung 1 study".
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 9, p. 1715, doi. 10.1002/cncr.35165
- Publication type:
- Article
Survival outcomes of patients with HER2/neu‐positive breast cancer with germline BRCA mutations.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 9, p. 1600, doi. 10.1002/cncr.35159
- By:
- Publication type:
- Article
Postradical prostatectomy prostate‐specific antigen outcomes after 6 versus 18 months of perioperative androgen‐deprivation therapy in men with localized, unfavorable intermediate‐risk or high‐risk prostate cancer: Results of part 2 of a randomized phase 2 trial
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 9, p. 1629, doi. 10.1002/cncr.35170
- By:
- Publication type:
- Article
Human papillomavirus infection affects treatment outcomes and the immune microenvironment in patients with advanced penile squamous cell carcinoma receiving programmed cell death protein 1 inhibitor–based combination therapy.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 9, p. 1650, doi. 10.1002/cncr.35177
- By:
- Publication type:
- Article
Immune checkpoint inhibitor use and the incidence of hepatitis B virus reactivation or immune‐related hepatitis in non–small cell lung cancer patients with chronic hepatitis B.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 9, p. 1693, doi. 10.1002/cncr.35175
- By:
- Publication type:
- Article
Plant‐based diet associated with better quality of life in prostate cancer survivors.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 9, p. 1618, doi. 10.1002/cncr.35172
- By:
- Publication type:
- Article
Impact of pretransplant minimal residual disease in patients with multiple myeloma and a very good partial response or better receiving autologous hematopoietic stem cell transplantation.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 9, p. 1663, doi. 10.1002/cncr.35171
- By:
- Publication type:
- Article
Data‐driven optimization of version 9 American Joint Committee on Cancer staging system for anal cancer.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 9, p. 1702, doi. 10.1002/cncr.35155
- By:
- Publication type:
- Article
Patient navigation job roles by levels of experience: Workforce Development Task Group, National Navigation Roundtable.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 9, p. 1549, doi. 10.1002/cncr.35147
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 9, p. 1539, doi. 10.1002/cncr.34295
- Publication type:
- Article